1. Home
  2. LSB vs GNLX Comparison

LSB vs GNLX Comparison

Compare LSB & GNLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LSB
  • GNLX
  • Stock Information
  • Founded
  • LSB 2002
  • GNLX 2001
  • Country
  • LSB China
  • GNLX United States
  • Employees
  • LSB N/A
  • GNLX N/A
  • Industry
  • LSB
  • GNLX Biotechnology: Pharmaceutical Preparations
  • Sector
  • LSB
  • GNLX Health Care
  • Exchange
  • LSB NYSE
  • GNLX Nasdaq
  • Market Cap
  • LSB 72.7M
  • GNLX N/A
  • IPO Year
  • LSB N/A
  • GNLX 2023
  • Fundamental
  • Price
  • LSB $3.80
  • GNLX $2.65
  • Analyst Decision
  • LSB
  • GNLX Strong Buy
  • Analyst Count
  • LSB 0
  • GNLX 3
  • Target Price
  • LSB N/A
  • GNLX $22.33
  • AVG Volume (30 Days)
  • LSB 115.6K
  • GNLX 112.8K
  • Earning Date
  • LSB 10-25-2024
  • GNLX 11-12-2024
  • Dividend Yield
  • LSB N/A
  • GNLX N/A
  • EPS Growth
  • LSB N/A
  • GNLX N/A
  • EPS
  • LSB N/A
  • GNLX N/A
  • Revenue
  • LSB $79,415,311.00
  • GNLX $8,000.00
  • Revenue This Year
  • LSB $39.33
  • GNLX N/A
  • Revenue Next Year
  • LSB $75.61
  • GNLX N/A
  • P/E Ratio
  • LSB N/A
  • GNLX N/A
  • Revenue Growth
  • LSB N/A
  • GNLX N/A
  • 52 Week Low
  • LSB $3.20
  • GNLX $1.60
  • 52 Week High
  • LSB $11.20
  • GNLX $22.16
  • Technical
  • Relative Strength Index (RSI)
  • LSB 33.85
  • GNLX 61.21
  • Support Level
  • LSB $3.20
  • GNLX $1.95
  • Resistance Level
  • LSB $4.14
  • GNLX $2.68
  • Average True Range (ATR)
  • LSB 0.72
  • GNLX 0.12
  • MACD
  • LSB -0.44
  • GNLX 0.03
  • Stochastic Oscillator
  • LSB 11.11
  • GNLX 95.89

About LSB LAKESHORE BIOPHARMA CO LTD

LakeShore Biopharma Co Ltd is a biopharmaceutical company dedicated to discovering, developing, manufacturing, and delivering new generations of vaccines and therapeutic biologics for infectious diseases and cancer. It has developed a proprietary PIKA immunomodulating technology platform and a new generation of preventive and therapeutic biologics targeting Rabies, Coronavirus, Hepatitis B, Influenza, Shingles, and other virus infections. The company operates in China, the United States, Singapore, and the Philippines.

Share on Social Networks: